Infiltrazione Endoparietale Di Orgoteina Nel Trattamento Delle Radiocistiti: Espcrienze Preliminari

Babior B. , Kipnes R. , Curnutte J. : Biological defense mechanism; the production by leukocytes of superoxide; a potential bactericidal agent. J. Clin. Invest., 52; 741 (1973).

Carson S. , Vogin E. E. , Huber W. , Schulte T. L. : Safety tests of orgotein, an antiflammatory protein. Toxicol. Appl. Pharm. 26 (1973).

Edsmyr F. , Menander-Huber K. B. : Orgotein efficacy in ameliorating side effects due to radiation therapy. Europ. J. Rheum. Inflamm., 4; 228 (1981).

Flohe L. , Loschen G. : Radicali di ossigeno come mediatori flogistici. Acta Peroxinorm II° Symposium. Frankfurt 1982.

Fridovich I. : Superoxide dismutases. Ann. Rev. Bioch., 44; 147 (1975).

Helmestein K. : Treatment of bladder carcinoma by a hydrostatic pressure technique: report on 76 cases. Pan-minerva med., 18; 194 (1976).

Huber W. , Schulte T. L. , Carson S. , Goldhammer R. E. , Vogin E. E. : Some chemical and pharmacologic properties of a nouvel anti-inflammatory protein. Toxicol. Appl. Pharm., 12; 308 (1968).

Kadrnka F. : Ergebnisse einer multizentrischen Orgoteinprüfung bei Strahlen und interstitiellen Cystitiden. Europ. J. Rheum. Inflamm., 4; 237 (1981).

Kappus H. : Tossicità dei radicali dell'ossigeno: funzioni biologiche ed effetti istolesivi. Peroxinorm II° Symposium, Frankfurt 1982.

Marberger H. , Huber W. , Bartsch G. , Schulte T. , Swoboda P. : Orgotein: a new anti-inflammatory, metallo-protein drug; evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Intern. Urol. & Nefrol., 6; 61 (1974).

Marberger H. , Bartsch G. , Huber W. , Menander K. B. , Schulte T. L. : Orgotein a new drug for the treatment of radiation cystitis. Curr. Therap. Res., 18; 3 (1975).

Menander-Huber K. B. , Edsmyr F. , Huber W. : Orgotein (superoxide dismutase): A drug for the amelioration of radiation-induced side effects. Urol. Research., 6; 4 (1978).

Sies H. : Formazione di radicali superossido e perossidi nell'organismo. Peroxinorm II%deg; Symposium, Frankfurt 1982.

Salin M. L. , McCord J. M. : Free radical and inflammation: Protection of phagocytosing leukocytes by superoxide dismutase. J. Clin. Invest., 55; (1975).

Schmidt J. D. : The evaluation of safety and efficacy of orgotein in urological disorders. Acta 50^th Congr. Pan-Amer. Med. Ass. 1976.

Rister M. : Liberazione fagocitgria di radicali superossido: fenomeno benefico o nocivo? Peroxinorm II° Symposium, Frankfurt 1982.